drugset / Trial / NCT03939364
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
RandomizedParallel-groupQuadruple-blindOther
Summary
This study will be the first study investigating the safety, pharmacokinetics (PK), and efficacy of SBS-101 on oral pre-malignant lesions. As such, no clinical data has yet been generated using SBS-101 oral adhesive film.
Timeline
- Start
- 2022-01
- Primary completion
- 2023-04
- Completion
- 2023-05
Outcome
Outcome not reported
Stopped: “Delays due to manufacturing and the COVID-19 pandemic”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SBS-101 | Unknown | 0.1 % | Other |
| Subject | SBS-101 | Unknown | 0.2 % | Other |
| Subject | SBS-101 | Unknown | 0.3 % | Other |